Summary
Mutations in sup1 and sup2 genes may cause cycloheximide-dependent growth in yeast Saccharomyces cerevisiae. Two classes of such mutants are described in the paper: 1) high temperature sensitive mutants, which do not express their sensitivity to nonpermissive temperature in the presence of cycloheximide (conditionally dependent) and 2) mutants unable to grow in the absence of the drug (true dependent). Some of the mutants of both classes express dependence toward another antibiotic — trichodermine. The binding of H3-labelled cycloheximide studied by equilibrium dialysis has demonstrated that both 80S ribosomes and 60S subunits isolated from conditionally dependent mutant showed a higher affinity for the drug compared to that of a parent strain. The number of binding sites per ribosome or per 60S subunit in the cycloheximide dependent mutant remains unchanged.
Circular dichroism spectra of a mutant ribosomes in the presence as well as in the absence of antibiotic revealed that sup1 and sup2 mutations alter conformation of the yeast cytoplasmic ribosomes. The binding of cycloheximide to mutant ribosomes induces a conformational shift, which presumably compensates for their functional defect.
Similar content being viewed by others
References
Allen SH, Wong KP (1979) Arch Biochim Biophys 195:112–120
Dabbs ER (1978) Mol Gen Genet 165:73–78
Dabbs ER (1979) J Bacteriol 140:734–734
Dabbs ER, Looman K (1981) Mol Gen Genet 184:224–229
Dabbs ER, Wittmann HG (1976) Mol Gen Genet 149:303–309
Fincham JRS, Baron YA (1977) J Mol Biol 110:627–634
Fried HM, Warner JR (1981) Proc Natl Acad Sci USA 78:238–242
Inge-Vechtomov SG (1971) Genetika 7:113–120 (in Russian)
Inge-Vechtomov SG, Andrianova VM (1972) In: Dubinin NP, Goldfarb DM (eds) The molecular mechanisms of genetic processes. Nauka, Moscow, pp 189–195 (in Russian)
Martinez O, Vazques D, Modolell J (1978) FEBS Letters 87:21–24
Mironova LN, Provorov NA, Ter-Avanesyan MD, Inge-Vechtomov SG, Surguchov AP, Smirnov VN (1982) Curr Genet 5:149–152
Noreau J, Grise-Miron L, Brakier-Gingras L (1980) Biochem Biophys Acta 608:72–81
Stocklein W, Piepersberg W (1980a) Antimicrobiol Agents and Chemotherapy 18:863–867
Stocklein W, Piepersberg W (1980b) Currr Genet 1:177–183
Surguchov AP, Berestetskaya YuV, Fominykch ES, Pospelova EM, Smirnov VN, Ter-Avanesyan MD, Inge-Vechtomov SG (1980) FEBS Letters 111:175–178
Surguchov AP, Berestetskaya YuV, Smirnov VN, Ter-Avanesyan MD, Inge-Vechtomov SG (1981a) FEMS Microbiology Letters 12:381–384
Surguchov AP, Fominykch ES, Smirnov VN, Ter-Avanesyan MD, Mironova LN, Inge-Vechtomov SG (1981b) Biochim Biophys Acta 654:149–155
Ter-Avanesyan MD, Schubochkina EA, Inge-Vechtomov SG (1982a) Genetika 18:215–222 (in Russian)
Ter-Avanesyan MD, Schubochkina EA, Inge-Vechtomov SG (1982b) Genetika 18:223–226 (in Russian)
van der Zeist BAM, Kees JM, Engel JM, Bloemers HPI (1973) Biochim Biophys Acta 294:517–526
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ter-Avanesyan, M.D., Mironova, L.N., Inge-Vechtomov, S.G. et al. Drug-dependent mutants in yeast Saccharomyces cerevisiae . Curr Genet 7, 357–362 (1983). https://doi.org/10.1007/BF00445875
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00445875